Before settling on a $5.4 billion price tag for Global Blood Therapeutics, Pfizer had to fight off a mysterious “company A.” Now, the identity of that contender has been revealed.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,